Amendment112th Congress
2111
- Amendment Number
- 2111
- Purpose
- To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.
- Congress
- 112
- Type
- SAMDT
- Latest Action Date
- May 24, 2012
- Latest Action Text
- Amendment SA 2111, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 28 - 67. Record Vote Number: 105.
- Proposed Date
- May 24, 2012
- Submitted Date
- May 17, 2012
- Chamber
- Senate
- Update Date
- Mar 4, 2019